Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3450)
All Articles published online
|
Oct 28, 2012 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee HJ, Kim YN, Jang HW, Jeon HH, Jung ES, Park SJ, Hong SP, Kim TI, Kim WH, Nam CM, Cheon JH. Correlations between endoscopic and clinical disease activity indices in intestinal Behcet's disease. World J Gastroenterol 2012; 18(40): 5771-5778 [PMID: 23155319 DOI: 10.3748/wjg.v18.i40.5771] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i40/5771.htm |
| Number | Citing Articles |
| 1 |
Hyun Jung Lee, Hye Sun Shin, Hui Won Jang, Seung Won Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon. Correlation between Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Endoscopic Activity in Intestinal Behçet's Disease. Yonsei Medical Journal 2014; 55(4): 960 doi: 10.3349/ymj.2014.55.4.960
|
| 2 |
Tsutomu Mizoshita, Satoshi Tanida, Takashi Joh. Adalimumab treatment in intestinal Behçet's disease: Relationship with ectopic mucin 5AC glycoprotein expression and endoscopic improvement. Digestive and Liver Disease 2015; 47(11): 991 doi: 10.1016/j.dld.2015.07.007
|
| 3 |
Jongwook Yu, Sung Jae Shin, Yune-Jung Park, Hyung Wook Kim, Bo-In Lee, Byong Duk Ye, Geun-Tae Kim, Sung Kook Kim, Joo Sung Kim, Young-Ho Kim, Seonjeong Jeong, Jae Hee Cheon. Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03090-x
|
| 4 |
Satoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, Makoto Naganuma, Fumihito Hirai, Bunei Iizuka, Kenji Watanabe, Keiichi Mitsuyama, Takuya Inoue, Yoshiaki Ishigatsubo, Yasuo Suzuki, Masakazu Nagahori, Satoshi Motoya, Shiro Nakamura, Vipin Arora, Anne M. Robinson, Roopal B. Thakkar, Toshifumi Hibi. Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease. Clinical Gastroenterology and Hepatology 2015; 13(5): 940 doi: 10.1016/j.cgh.2014.08.042
|
| 5 |
Hyun Jung Lee, Jae Hee Cheon. Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease. Intestinal Research 2017; 15(3): 311 doi: 10.5217/ir.2017.15.3.311
|
| 6 |
Kun He, Dong Wu. The treatment principles and targets for intestinal Behcet’s disease. Therapeutic Advances in Gastroenterology 2023; 16: 175628482311672 doi: 10.1177/17562848231167283
|
| 7 |
Liang Gong, Yue Lun Zhang, Lu Xi Sun, Guo Rong Chen, Dong Wu. Mucosal healing in intestinal Behçet's disease: A systematic review and meta‐analysis. Journal of Digestive Diseases 2021; 22(2): 83 doi: 10.1111/1751-2980.12965
|
| 8 |
Jae Hee Cheon. Advances in Endoscopy in Inflammatory Bowel Disease. 2018; : 85 doi: 10.1007/978-4-431-56018-0_9
|
| 9 |
Ippei Miyagawa, Kazuhisa Nakano, Shigeru Iwata, Shingo Nakayamada, Kazuyoshi Saito, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Akio Kawabe, Yusuke Miyazaki, Yoshiya Tanaka. Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease. Arthritis Research & Therapy 2019; 21(1) doi: 10.1186/s13075-019-1933-8
|
| 10 |
Ryosuke Miyazaki, Toshiyuki Sakurai, Yuko Iwashita, Mariko Shimada, Naoki Shibuya, Yoshihiro Akita, Haruna Miyashita, Yuki Maruyama, Ryoichi Sawada, Takahiko Toyonaga, Kazuki Takakura, Masayuki Saruta. Characteristics and Endoscopic Classification of Ulcerative Lesions Affecting the Ileocecal Valve. Digestive Diseases 2022; 40(2): 239 doi: 10.1159/000516975
|
| 11 |
Tadakazu Hisamatsu, Makoto Naganuma, Katsuyoshi Matsuoka, Takanori Kanai. Diagnosis and management of intestinal Behçet’s disease. Clinical Journal of Gastroenterology 2014; 7(3): 205 doi: 10.1007/s12328-014-0488-0
|
| 12 |
Jae Hee Cheon. Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists. Journal of Rheumatic Diseases 2021; 28(1): 4 doi: 10.4078/jrd.2021.28.1.4
|
| 13 |
Shunji Fujimori. Asymptomatic small intestinal ulcerative lesions: Obesity and <i>Helicobacter pylori </i>are likely to be risk factors. World Journal of Gastroenterology 2021; 27(28): 4484-4492 doi: 10.3748/wjg.v27.i28.4484
|
| 14 |
|
| 15 |
Tadakazu Hisamatsu, Mari Hayashida. Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease. Intestinal Research 2017; 15(3): 318 doi: 10.5217/ir.2017.15.3.318
|
| 16 |
Simona Valenti, Romina Gallizzi, Dominique De Vivo, Claudio Romano. Intestinal Behçet and Crohn’s disease: two sides of the same coin. Pediatric Rheumatology 2017; 15(1) doi: 10.1186/s12969-017-0162-4
|
| 17 |
Duk Hwan Kim, Jae Hee Cheon. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?. Yonsei Medical Journal 2016; 57(1): 22 doi: 10.3349/ymj.2016.57.1.22
|
| 18 |
Ibrahim Hatemi, Gulen Hatemi, Aykut Ferhat Çelik. Gastrointestinal Involvement in Behçet Disease. Rheumatic Disease Clinics of North America 2018; 44(1): 45 doi: 10.1016/j.rdc.2017.09.007
|
| 19 |
Kenji Watanabe, Satoshi Tanida, Nagamu Inoue, Reiko Kunisaki, Kiyonori Kobayashi, Masakazu Nagahori, Katsuhiro Arai, Motoi Uchino, Kazutaka Koganei, Taku Kobayashi, Mitsuhiro Takeno, Fumiaki Ueno, Takayuki Matsumoto, Nobuhisa Mizuki, Yasuo Suzuki, Tadakazu Hisamatsu. Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants. Journal of Gastroenterology 2020; 55(7): 679 doi: 10.1007/s00535-020-01690-y
|
| 20 |
Wasseem Skef, Matthew J Hamilton, Thurayya Arayssi. Gastrointestinal Behçet's disease: A review. World Journal of Gastroenterology 2015; 21(13): 3801-3812 doi: 10.3748/wjg.v21.i13.3801
|
| 21 |
Duk Hwan Kim, Yehyun Park, Bun Kim, Seung Won Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon. Fecal calprotectin as a non‐invasive biomarker for intestinal involvement of Behçet's disease. Journal of Gastroenterology and Hepatology 2017; 32(3): 595 doi: 10.1111/jgh.13530
|
| 22 |
Ayaka Fukui, Yoichi Nakayama, Tsuneyasu Yoshida, Kosaku Murakami, Keiichiro Kadoba, Hideo Onizawa, Shuji Akizuki, Ran Nakashima, Hajime Yoshifuji, Koichiro Ohmura, Akihiko Sugimoto, Shuji Yamamoto, Akio Morinobu. A case of intestinal amoebiasis mimicking intestinal Behçet’s disease. Modern Rheumatology Case Reports 2022; 6(2): 270 doi: 10.1093/mrcr/rxac028
|